Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Deborah Dunsire currently holds 14,058 shares of Ultragenyx Pharmaceutical Inc. (RARE), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Deborah Dunsire has been a net seller of RARE stock. They have purchased $11.8K and sold $2.8M worth of shares.
Deborah Dunsire's most recent insider trade was on May 14, 2026, when they sold 14,058 shares at $0.00 per share.
Deborah Dunsire serves as Executive at Ultragenyx Pharmaceutical Inc. (RARE). They have executed 60 insider transactions totaling $2.8M over their tenure at the company.
Deborah Dunsire holds the position of Executive at Ultragenyx Pharmaceutical Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Deborah Dunsire has shown a selling trading pattern, with $11.8K in total purchases and $2.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Deborah Dunsire was on May 14, 2008, when they sold $17.2M worth of MLNM shares. This transaction involved 688,957 shares at $25.00 per share.
Deborah Dunsire currently owns 14,058 shares of Ultragenyx Pharmaceutical Inc. (RARE), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Deborah Dunsire's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Deborah Dunsire has 60 Form 4 filings on record as an insider at Ultragenyx Pharmaceutical Inc..
Set alerts for Deborah Dunsire and 40,000+ other insiders.